South Texas Accelerated Research Therapeutics:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:South Texas Accelerated Research Therapeutics - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10926
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
South Texas Accelerated Research Therapeutics (START) accelerates the development of novel anticancer agents that improves personalized and clinical care for cancer patients. The company offers preclinical and clinical research services which include pharmacokinetics, in vivo and in vitro services; regulatory affairs support; drug investigation studies; preclinical models and assays to accelerate oncology drug development; and others. It also conducts phase I medical oncology programs using innovative information technology infrastructure for rapid clinical trials, as well as patient tumor model program to accelerate drug discovery and development for the treatment of cancer. The company has operations with offices in the China and Spain. START is headquartered in San Antonio, Texas.

South Texas Accelerated Research Therapeutics – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
South Texas Accelerated Research Therapeutics, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
South Texas Accelerated Research Therapeutics, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
South Texas Accelerated Research Therapeutics, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
South Texas Accelerated Research Therapeutics, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
South Texas Accelerated Research Therapeutics, Medical Devices Deals, 2012 to YTD 2018 9
South Texas Accelerated Research Therapeutics, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
South Texas Accelerated Research Therapeutics, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
South Texas Accelerated Research Therapeutics and Sarah Cannon Research Institute Enter into Partership 11
SA1KCGP, WuXi NextCODE and START Enter into Partnership 12
Denovo Sciences Enters into Research Agreement with South Texas Accelerated Research Therapeutics 13
South Texas Accelerated Research Therapeutics – Key Competitors 14
South Texas Accelerated Research Therapeutics – Key Employees 15
South Texas Accelerated Research Therapeutics – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
South Texas Accelerated Research Therapeutics, Pharmaceuticals & Healthcare, Key Facts 2
South Texas Accelerated Research Therapeutics, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
South Texas Accelerated Research Therapeutics, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
South Texas Accelerated Research Therapeutics, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
South Texas Accelerated Research Therapeutics, Deals By Therapy Area, 2012 to YTD 2018 8
South Texas Accelerated Research Therapeutics, Medical Devices Deals, 2012 to YTD 2018 9
South Texas Accelerated Research Therapeutics, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
South Texas Accelerated Research Therapeutics and Sarah Cannon Research Institute Enter into Partership 11
SA1KCGP, WuXi NextCODE and START Enter into Partnership 12
Denovo Sciences Enters into Research Agreement with South Texas Accelerated Research Therapeutics 13
South Texas Accelerated Research Therapeutics, Key Competitors 14
South Texas Accelerated Research Therapeutics, Key Employees 15
South Texas Accelerated Research Therapeutics, Other Locations 16

List of Figures
South Texas Accelerated Research Therapeutics, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
South Texas Accelerated Research Therapeutics, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
South Texas Accelerated Research Therapeutics, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
South Texas Accelerated Research Therapeutics, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
South Texas Accelerated Research Therapeutics, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
South Texas Accelerated Research Therapeutics, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
South Texas Accelerated Research Therapeutics, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
South Texas Accelerated Research Therapeutics, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
South Texas Accelerated Research Therapeutics, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[South Texas Accelerated Research Therapeutics:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Grant Thornton International Ltd:企業の戦略的SWOT分析
    Grant Thornton International Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • OncoSil Medical Limited (OSL):企業の財務及び戦略的SWOT分析
    Summary OncoSil Medical Limited (OncoSil), formerly NeuroDiscovery Limited is a biotechnology company that develops and commercializes products for the neurology market. The company offers products such as NDL-101, and NSL-043. OncoSil’s NDL-101 is a natural product formulation which is developed as …
  • Cancer Research Technology Ltd-医療機器分野:企業M&A・提携分析
    Summary Cancer Research Technology Ltd (CRT), formerly Cancer Research Campaign Technology Ltd, a subsidiary of Cancer Research UK, is a research organization that develops and commercializes discoveries for treatment in the areas of cancer. The organization offers services such as project developme …
  • Veolia Water(エネルギー分野):企業M&A動向
    Summary Veolia Water is a company that provide water and waste management services. It designs technical solutions and builds facilities to provide water and wastewater services for public and private authorities. The major business activities of the company include production and distribution of dr …
  • Xeikon N.V. (XEI):企業概要及び戦略的SWOT分析
    Xeikon N.V. (XEI) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • PowerComm, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' PowerComm, Inc. Mergers and Acq …
  • Terna S.p.A.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Terna S.p.A. Mergers and Acquis …
  • Axela Inc:製品パイプライン分析
    Summary Axela Inc (Axela), formerly Axela Biosensors Inc is a provider of optic technology solutions. The company offers Ziplex system, Flow-thru TipChips, panelPlus TipChips, diffractive optics technology, diffractive optics sensors, panelPlus sensors and software products. It offers technical and …
  • Mitsubishi Corporation (8058):企業のM&A・提携動向(エネルギー分野)
    Summary Mitsubishi Corporation (Mitsubishi) is a diversified business company. Mitsubishi operates in industries including energy, metals, chemicals, machinery, foods, industrial finance and environmental business, among others. The company classifies its business operations into seven business segm …
  • Gemini Corporation (GKX):企業財務及び戦略的SWOT分析
    Summary Gemini Corporation (Gemini) is an oil and gas engineering company that provides engineering, field and environmental solutions. The company offers services including project management systems, fabrication, maintenance, procurement, construction, land, environmental, regulatory, and reclamat …
  • Radboud University Medical Centre:製薬・医療:M&Aディール及び事業提携情報
    Summary Radboud University Medical Centre (Radboud UMC), a subsidiary of Radboud University, is a university medical center that offers patient care, education, research, and scientific training services. The centre’s patient care services include basic care, tertiary care, top referral care, and tr …
  • Damodar Valley Corp:電力:M&Aディール及び事業提携情報
    Summary Damodar Valley Corp (DVC) is a government owned multi-purpose river valley project. It generates, transmits, and supplies electricity; mines for and produces coal; manages water and conserves soil; and provides consultancy services. The company produces energy using thermal and hydro sources …
  • Coal of Africa Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Coal of Africa Limited Mergers …
  • OSE Immunotherapeutics (OSE):企業財務及び戦略的SWOT分析
    Summary OSE Immunotherapeutics (OSE) is a biopharmaceutical company that discovers and develops immunotherapy products against invasive and metastatic late-stage cancers. The company’s proprietary technology, Memopi, is employed in the studying the development of treatments for ovarian, colon and br …
  • Pan Orient Energy Corp. (POE)(石油・ガス分野):企業M&A動向
    Summary Pan Orient Energy Corp. (POE) is an oil and natural gas company. The company explores and produces the oil and gas in Asia. Its principal properties are divided into three distinct groups, which include partially developed concessions located on-shore Thailand, interests in production sharin …
  • NanoString Technologies Inc (NSTG):企業の財務・戦略的SWOT分析
    Summary NanoString Technologies Inc (NanoString) is a developer of life science tools for translational research and molecular diagnostics. The company's products include sprint profiler, Dx analysis system with flex, nCounter MAX analysis system, protein assays, solid tumor assays, gene fusion pane …
  • OBJ Ltd (OBJ):医療機器:M&Aディール及び事業提携情報
    Summary OBJ Ltd (OBJ) is a developer of magnetic micro-array drug and ingredient delivery technologies. The company offers services such as drug or ingredient profiling in skin, laboratory facilities and capabilities, formulation development, product development, product optimisation, and pre-commer …
  • TA Enterprise Berhad:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' TA Enterprise Berhad Mergers an …
  • Axion Power International, Inc. (AXPW):企業のM&A・提携動向(エネルギー分野)
    Summary Axion Power International, Inc. (Axion Power) is an energy equipment manufacturer that designs, develops, manufactures and sells energy storage components and devices. The company offers products like batteries, PowerCube mobile energy storage system and UPS. Its advanced energy storage prod …
  • Milliken and Company:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Milliken and Company Mergers an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆